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Abstract
Obesity is considered a mild inflammatory state, and the secretion of inflammation-related cytokines rises as adipose tissue expands. Inflammatory
cytokines, including tumor necrosis factor-α (TNF-α), interlukin 6 (IL-6) and monocyte-chemoattractant protein 1 (MCP-1), are modulated by adipose
tissue and known to play an important role in insulin resistance which is the common characteristics of obesity related disorders. In this study
we analyzed the effects of Sasa borealis leaves extract on inflammatory cytokines and insulin resistance in diet induced obese C57/BL6J mice.
The obese state was induced by a high fat diet for 20 weeks and then the mice were divided into two groups; obese control group (OBC, n = 7)
and experimental group (OB-SBE, n = 7). The OBC group was fed a high fat diet and the OB-SBE group was fed a high fat diet containing 5% 
Sasa borealis leaves extract (SBE) for 12 weeks. We also used mice fed a standard diet as a normal control (NC, n = 7). The body weight and 
adipose tissue weight in the OB group were significantly higher than those in the NC group. The effects of the high fat diet were reduced by
SBE treatments, and the body weight and adipose tissue deposition in the OB-SBE group were significantly decreased compared to the OBC group.
The OBC group showed higher serum glucose and insulin levels which resulted in a significant increase of incremental area under the curve (IAUC)
and HOMA-IR than the NC group. Also, serum leptin, TNF-α, and IL-6 levels were significantly higher in the OBC group than in the NC group.
In contrast, the OB-SBE group showed a reversal in the metabolic defects, including a decrease in glucose, insulin, IAUC, HOMA-IR, TNF-α, 
IL-6 and leptin levels. These results suggest that BSE can suppress increased weight gain and/or fat deposition induced by a high fat diet and
theses effects are accompanied by modulation of the inflammatory cytokines, TNF-α and IL-6 secretion resulting in improved insulin resistance.
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Introduction2)
Obesity and associated comorbidities are worldwide health 
problems. It is widely accepted that obesity results from 
disequilibrium between energy intake and expenditure, however 
nowadays adipose tissue is recognized as a major endocrine and 
secretory organ, releasing a wide range of protein factors and 
signals termed adipokines. Obesity is characterized by a state 
of mild inflammation, and the expression and release of 
inflammation-related adipokines generally rise as adipose tissue 
expands [1,2]. Inflammatory markers such as tumor necrosis 
factor-α (TNF-α), interlukin 6 (IL-6), and monocyte-chemoa-
ttractant protein 1 (MCP-1) are increased in obese individuals 
compared with lean subjects, although not to the same extent 
observed in classic inflammatory conditions. The presence of 
systemic inflammation has been linked to the increased risk of 
development of insulin resistance, type II diabetes, cardiovascular 
disease and other metabolic disorders associated with obesity 
[3-5].
There has been a substantial effort toward understanding the 
mechanisms underlying obesity induced metabolic disorders and 
numerous studies have been conducted looking for natural active 
products, especially medicinal plant sources, for therapeutic 
intervention to prevent and/or cure obesity and related disorders 
with few side effects. However, mechanistic studies related to 
cytokine modulation by medicinal plant sources are rare. Bamboo 
has been used for medicinal purposes for centuries in Korea and 
other Asian countries and its efficacy has been recorded in the 
materia medica, DongEuiBoGam in Korea [6-8]. Recent 
scientific research has shown health benefits of bamboo leaves 
[8-16], culm [17], shoot [18], shavings [19] and oils [20,21]. 
It has been shown that the medicinal effects of Sasa borealis, 
a species of bamboo, are predominantly anti-diabetic through 
enhancing insulin secretion [11], hypoglycemic and hypolipidemic 
effects [10,14-16], anti-obesity [10] and/or anti-oxidant effects 
[13]. It has recently been used as plain extraction or blend tea, 
hamburger patties, and complementary and alternative agent to 
demonstrate beneficial health effects [12,14]. In spite of the 
usefulness in the treatment for obesity and related metabolic 
disorders, the mechanism of these effects, focused on cytokine 
regulation, is rare and still remains to be solved. Our previous 
study revealed that the intake of Sasa borealis leaf extracts had 
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Fig. 1. Changes of body weight during the experimental periods. Group abbreviation: 
NC; mice fed normal diet, OBC; mice fed the high fat diet, OB-SBE; mice fed the 
diet containing 5% Sasa borealis leaves extract. Mean values with * or different letters 
are  significantly  different  by  repeated-measures  ANOVA  at  P < 0.05.
a beneficial effect on adiponectin and resistin levels and related 
molecules such as C-reactive protein and homocysteine levels 
which are involved in cardiovascular disease [10]. 
In this study, we tested whether the intake of extracts of Sasa 
borealis leaves modulates the production of the inflammatory 
cytokines TNF-α, IL-6 and MCP-1, which are involved in insulin 
resistance, on diet induced obesity. 
Materials and Methods
Sasa borealis leaves extract (SBE)
Sasa borealis leaves collected from the area of Chuwall 
mountain, at Damyang province in Korea were steamed for 
30min, dried and ground to a fine powder, and then extracted 
with 70% ethanol for 20 hours at 95℃. The resulting extracts 
were filtered, concentrated under vacuum at 60℃, and stored 
at 4℃ until used. The extraction yield of SBE was 10.4% (g/100 
g, w/w).
Animals and diets
Twenty one male C57BL/6J mice, aged 4 wk, were purchased 
from Charles River Laboratories (Tokyo, Japan). The animals 
were maintained on a standard chow diet (Jeil-jedang, Suwon, 
Korea) for 1 week, and then divided into two groups, normal 
diet (NC, n = 7) and high fat diet (OBC, n = 14) group. To make 
diet induced obese mice, OBC group was fed a high fat diet, 
with 60% of calories coming from fat (D12451, Research Diets, 
Ins., New Brunswick, NJ, USA) for 20 weeks. The NC group 
was fed a standard fat diet, with 10% of calories coming from 
fat (D12450B, Research Diets, Inc., New Brunswick, NJ, USA). 
The induction of obesity was confirmed by checking the body 
weight (Fig. 1). The obese mice were randomly divided into two 
groups such that the average weight in each group was 
comparable, OBC group (n = 7) and high fat diet containing 5% 
Sasa borealis leaves extract (OB-SBE, n = 7) group. During the 
12 week experimental periods, NC and OBC groups were fed 
the standard fat and high fat diet, respectively, and the OB-SBE 
group was fed high fat diet containing 5% SBE. The optimal 
level of BSE in the diet was determined in previous studies [9], 
which showed that the anti-obesity effect of Sasa borealis leaves 
extract was highest in 5% ethanol extracts (70%). The food 
consumption and body weight were measured daily and weekly, 
respectively. The mice were maintained in accordance with 
Guidelines for Care and Use of Laboratory Animals of Chonnam 
National University. The animals were housed in a polycarbonate 
cage in a temperature, humidity-controlled (23 ± 1℃, 53 ± 2%) 
room and maintained on a light cycle (12 h/12 h light/dark) with 
free access to food and water. At the end of the experiment, 
the mice were deprived of food for 12 hours and then 
anesthetized. The experimental protocols were approved by the 
Animal Ethics Committee of Chonnam National University. 
Collection of blood and tissue samples
Blood was collected after 12 hours of fasting by orbital cardiac 
puncture and put on ice water for 1 hour. Serum was separated 
by centrifugation at 1,100 × g for 15 min. at 4℃ (Micro 17R, 
Vision Scientific Co., Seoul, Korea), and stored at -20℃ until 
analyzed. After blood collection, organs such as liver, kidney 
and pancreas were surgically removed, and the adipose tissue 
was collected from epididymal and retroperitoneal fat. The 
samples were rinsed with phosphate-buffered saline solution, 
wiped with a paper towel, weighed, immediately frozen in liquid 
nitrogen and stored at -80℃ until analyzed. 
Analysis of glucose levels and glucose tolerance test (OGTT)
Glucose tolerance test was carried out at the end of the 
experiment during the fasting state. A 75% glucose solution (3.0 
g/kg body weight) was orally applied to each mouse using an 
intubation tube. Blood from the tail (20 ul) was taken every 30 
min from 0 min to 120 min after the glucose solution load. Blood 
glucose levels were measured by glucose oxidase method using 
a portable blood glucose monitor (model Super Glucocard Ⅱ, 
KDK, Japan). The positive incremental area under the curve 
(IAUC) was calculated using the Tapezoidal rule [22]. 
Analysis of serum insulin and leptin levels and homeostasis 
model assessment of insulin resistance (HOMA-IR)
Serum insulin and leptin levels were analyzed by Enzyme- 
Linked Immunosorbent Assay (ELISA). The analysis was 
conducted utilizing a mouse insulin assay kit (Mercodia AB, 
Uppsala, Sweden) and a mouse leptin assay kit (BioVendor 
Laboratories Std., Modrice, Czech Republic). The sample was 
thawed, appropriately diluted with assay diluents, and assayed. 
The homeostasis model assessment of insulin resistance (HOMA- 
IR) was calculated as described by Hosker et al. [23], HOMA-IRJung-Hwa Yang et al. 101
Table 1. The effects of SBE on body weight and food intake
NC OBC OB-SBE
Body weight
Initial weight (g) 27.5 ± 0.8
b 46.8 ± 1.5
a 46.3 ± 1.3
a
Final weight (g) 30.4 ± 0.9
c 50.7 ± 1.5
a 44.3 ± 1.2
b
Weight gain (g/12 wks) 2.9 ± 0.4
a 3.9 ± 1.0
a -2.1 ± 0.7
b
Food intake
Food intake (g/12 wks) 270.7 ± 7.5
  278.2 ± 7.6 272.2 ± 8.2
Calorie intake (kcal/12 wks) 1,042.2 ± 28.7
b 1,457.5 ± 39.6
a 1,426.1 ± 43.2
a
Food efficiency ratio (×10-
2)1 . 1 ± 0 . 2
a 1.4 ± 0.4
a -0.8 ± 0.3
b
Group  abbreviation:  NC;  mice  fed  normal  diet,  OBC;  mice  fed  the h i g h  f a t  d i e t ,  
OB-SBE;  mice  fed  the  diet  containing  5%  Sasa  borealis  leaves  extract.
Values are mean±SE of 7 mice. Mean values with different letters are significantly 
d i f f e r e n t  b e t w e e n  t h e  t h r e e  g r o u p s  b y  A N O V A  w i t h  T u k e y’s  test  at  P < 0.05. 
Food  efficiency  ratio  =  weight  gain  (g/12  wk)  /  food  intake  (g/12  wk) 
Table 2. The effects of SBE on adipose tissue weight 
NC OBC OB-SBE
Total fat pad weight (g) 1.03 ± 0.16
c 3.33 ± 0.18
a 2.70 ± 0.11
b
Retroperitoneal fat pad weight (g) 0.25 ± 0.05
c 1.27 ± 0.05
a 0.76 ± 0.05
b
Epididymal fat pad weight (g) 0.78 ± 0.12
b 2.06 ± 0.15
a 1.95 ± 0.10
a
Total fat pad weight/ body weight  0.03 ± 0.00
b 0.07 ± 0.01
a 0.06 ± 0.00
a
Group  abbreviation:  NC;  mice  fed  normal  diet,  OBC;  mice  fed  the h ig h  fa t d ie t, 
OB-SBE;  mice  fed  the  diet  containing  5%  Sasa  borealis  leaves  extract.
Values  are  mean ± SE  of  7  mice.  Mean  values  different  letters  are  significantly 
d i f f e r e n t  b e t w e e n  t h e  t h r e e  g r o u p s  b y  A N O V A  w i t h  T u k e y’s  test  at  P < 0.05. 
Table 3. The effects of SBE on serum glucose, insulin and leptin levels and 
HOMA-IR
NC OBC OB-SBE
Serum glucose (mg/ml) 125.9 ± 4.8
b 157.1 ± 6.3
a 130.4 ± 4.4
b
Serum insulin (μU/ml) 10.49 ± 2.05
b 99.9 ± 22.8
a 38.1 ± 7.29
ab
HOMA-IR 3.2 ± 0.6
b 39.1 ± 8.9
a 13.0 ± 2.8
b
Serum leptin (pg/ml) 319.5 ± 121.8
c 4881.3 ± 335.5
a 3685.2 ± 142.5
b
Group  abbreviation:  NC;  mice  fed  normal  diet,  OBC;  mice  fed  the h ig h  fa t d ie t, 
OB-SBE;  mice  fed  the  diet  containing  5%  Sasa  borealis  leaves  extract.
Values are mean ± SE of 7 mice. Mean values with different letters are significantly 
d i f f e r e n t  b e t w e e n  t h e  t h r e e  g r o u p s  b y  A N O V A  w i t h  T u k e y’s  test  at  P < 0.05. 
= [fasting insulin (μU/mL) × fasting glucose (mmol/L)] / 22.5.
Analysis of serum inflammatory cytokines levels
Serum inflammatory cytokines levels were analyzed by ELISA. 
The analysis was conducted utilizing a mouse TNF-α assay kit 
(BioSource International, Inc., California, USA), a mouse IL-6 
assay kit (BioSource International, Inc., California, USA), or a 
mouse MCP-1 assay kit (BioSource International, Inc., California, 
USA). The sample was thawed, appropriately diluted with assay 
diluents, and assayed. 
Statistical analysis
All values were expressed as group means ± SE. The statistical 
analyses were performed on an SPSS version 12.0 (SPSS Inc, 
Chicago, IL, USA). One way analysis of variance (ANOVA) 
followed by Tukey’s test was used to examine the differences 
between groups. All time dependent data were analyzed by 
repeated-measures ANOVA. Statistical significance was considered 
at  P < 0.05.
Results
Body weight and weight gain 
As shown in Table 1, at the beginning of the experiment, the 
weight of NC group was significantly lower than those of OBC 
and OB-SBE groups whereas there was no significant difference 
in weight between the OBC and OB-SBE group. At the end of 
the experiment, SBE treatment led a significant weight reduction 
resulting that the weight of OB-SBE group was significantly 
lower than that of the OBC group. 
Food intake and feed efficiency 
The caloric intake of the animals is shown in Table 2. There 
was no significant difference in feed consumption among the 
NC and OBC groups, either with or without SBE, however the 
caloric intake was significantly lower in the NC group than in 
both the OBC and OB-SBE groups. The feed efficiency ratio 
was significantly lower in the OB-SBE group than in the NC 
and OBC groups. Treatment with SBE significantly decreased 
the feed efficiency ratio and resulted in a negative feed efficiency 
ratio. 
Body fat pad weight and organ weight
Body fat pad weight is shown in Table 2. The epididymal and 
retroperitoneal fat pad weights were significantly lower in the 
NC group than in the OBC group. BSE treatment led to lower 
retroperitoneal fat deposition resulting that the retroperitoneal fat 
pad weight was significantly lower in OB-SBE than OBC group. 
However, there was no significant difference in epididymal fat 
pad deposition between the OBC and OB-SBE group. The body 
fat pad weight to body weight ratio was significantly lower in 
NC group than in OBC and OB-SBE groups. SBE treatment 
showed no significant effect on the body fat pad weight to body 
weight ratio in OB-SBE group. 
Serum glucose, insulin and leptin levels
The effects of high fat diet and SBE treatment on serum 
glucose, insulin and leptin levels are shown in Table 3. Fasting 
serum glucose, insulin and leptin levels were significantly higher 
in the OBC group than in the NC group. SBE treatment 
significantly lowered all levels in the OB-SBE group compared 
to OBC group. The predominant effects of high fat diet were 
on serum leptin levels, which were significantly increased almost 
tenfold. 102 The effect of Sasa borealis on insulin resistance
         
Fig. 2. The effects of SBE on incremental blood glucose levels (left) and incremental area under the curve (right) after oral glucose tolerance test. Group abbreviation:
NC; mice fed normal diet, OBC; mice fed the high fat diet, OB-SBE; mice fed the diet containing 5%  Sasa borealis leaves extract. Mean values with different letters are 
significantly  different  between  the  three  groups  by  ANOVA  with  Tukey’s  test  at  P < 0.05. 
               
Fig. 3. The effects of SBE on serum inflammatory cytokine levels. Group abbreviation: NC; mice fed normal diet, OBC; mice fed the high fat diet, OB-SBE; mice fed 
the diet containing 5% Sasa borealis leaves extract. Mean values with different letters are significantly different between the three groups by ANOVA with Tukey’s test at 
P < 0.05. 
Oral glucose tolerance test (OGTT) and homeostasis model 
assessment of insulin resistance (HOMA-IR)
The area under the curve (AUC) calculated from the oral 
glucose tolerance test is shown in Fig 2. The incremental AUC 
was significantly high in the OBC group compared to the NC 
group. BSE treatment significantly decreased the incremental 
AUC in the OB-SBE group compared to the OBC group. The 
effects of high fat diet and SBE treatment on HOMA-IR 
corresponded with insulin levels, which were significantly higher 
in the OBC group than in the NC group, and BSE treatment 
significantly decreased HOMA-IR in the OB-SBE group compared 
to the OBC group.
Serum inflammatory cytokines levels
Serum inflammatory cytokines levels are shown in Fig 3. The 
TNF-α and IL-6 levels were significantly higher in the OBC 
group than in the NC group whereas there was no difference 
in MCP-1 levels between the OBC and NC group. SBE treatment 
significantly decreased TNF-α and IL-6 levels and there was no 
significant change in MCP-1 levels in the OB-SBE group. 
Discussion
The present study clearly shows that dietary fat has an effect 
on the development of obesity in mice. Our results support 
previous studies which showed that a high fat diet induced higher 
body fat deposition and increased body weight. Although feed 
consumption was not significantly different, the increased caloric 
density of high fat diet led to significantly higher weight gain 
compared with the normal diet which resulted in higher feed 
efficiency. Thus, mice fed high fat diet in the OBC group showed 
more rapid weight gain and greater fat pad deposition than mice 
fed normal diet in the NC group. However, the higher weight 
gain and feed efficiency exhibited by the OBC group were 
reduced by SBE treatment. Although feed and caloric intakes 
were not significantly different, the body weight of the OBC Jung-Hwa Yang et al. 103
group was increased whereas that of the OB-SBE group was 
decreased and resulted in negative feed efficiency ratio. The SBE 
treatment significantly decreased retroperitoneal fat deposition 
whereas epididymal fat deposition was not changed. Changes in 
body fat deposition and organ weights were reflected to body 
weight changes (data were not shown). These results suggest that 
SBE can suppress the increase in weight gain or fat deposition, 
especially in retroperitoneal fat induced by high fat diet. Adipose 
tissue has been long considered as an active tissue, primarily 
responsible for storing lipids in times of food plenty and releasing 
them when energy is restricted. Recent studies have demonstrated 
that adipose tissue plays an important role in energy regulation 
as well as whole body homeostasis via endocrine, paracrine and 
autocrine signals [24,25]. Leptin is a well-known obesity index 
produced by adipose tissue. In this study body fat accumulation 
was increased by high fat diet and correlated with body weight, 
fat content, and a marker of obesity, serum leptin levels increased 
accompanying a high fat diet. Thus, at the end of the experimental 
period, serum leptin levels were significantly higher in the OBC 
group compared to the NC group, whereas serum leptin levels 
were significantly decreased by BSE treatment in the OB-BSE 
group. However, leptin levels were still higher in the OB-SBE 
group compared to the NC group. These changes parallel with 
changes in adipose tissue depositions, especially in the retroperitoneal 
fat. In this study, we showed that SBE has a potential for weight 
reduction, especially in the retroperitoneal fat deposition, in mice 
fed a high fat diet, which is in agreement with other studies 
[9,10]. 
Several studies, including in vitro [11], animal studies [9,10] 
and human studies [12,14], have reported that BSE has beneficial 
effects in controlling serum glucose levels. However, in those 
studies only one or two indices were checked among the serum 
glucose, insulin levels, IAUC from OGTT or HOMA-IR. In this 
study we analyzed all of the integral indices to confirm the effects 
of SBE on glucose regulation by measuring serum glucose and 
insulin levels as well as calculating IAUC and HOMA-IR as an 
index of insulin resistance. Insulin resistance is defined as a 
decreased response of peripheral tissues to insulin action resulting 
in a hyperglycemic state and has been recognized as the integral 
feature of metabolic syndrome, which includes glucose intolerance, 
insulin resistance, obesity, hypertriglyceridemia, low HDL- 
cholesterol and hypertension. Growing evidence has pointed to 
a correlative and causative relationship between inflammation 
and insulin resistance. Xu et al. [26] reported that an 
inflammatory response is a general phenomenon of the obese 
state regardless of genetic or diet induced obesity (DIO) and the 
phenomenon was white adipose tissue (WAT) specific and was 
not observed in any other tissues including liver, lung, spleen 
and muscle. Also, Xu et al. [26] revealed that numerous 
inflammation and macrophage-specific genes are dramatically 
up-regulated in the white adipose tissue in both obese models. 
The up-regulation is progressively increased in WAT in DIO and 
precedes a dramatic increase in the circulating insulin level. Xu 
et al. [26] proposed a hypothesis that obesity-related insulin 
resistance is, at least in part, a chronic inflammatory disease 
initiated in adipose tissue. In the present study, the OBC group 
gained more adipose tissue and showed higher serum glucose 
and insulin levels compared to the NC group and resulted in 
a significantly increased insulin resistance as defined by 
HOMA-IR. The results from our study were in agreement with 
the above hypothesis. Also, our results showed that BSE 
treatment improves all of the indices and suggests that BSE has 
the potential to improve insulin resistance induced by a high fat 
diet. 
To explore the relationship of inflammatory cytokines in 
obesity and insulin resistance, we analyzed TNF-α, IL-6 and 
MCP-1 levels. The inflammatory cytokine TNF-α  has been 
demonstrated to mediate insulin resistance as a result of obesity 
in many rodent obesity models [26,27]. TNF-α  is the first 
adipocytokine suggested to be a molecular link between obesity 
and inflammation since its levels are increased in the adipose 
tissue in the obese state and its increase impairs insulin sensitivity 
[27,28]. Recently, the MCP-1 was also shown to impair adipocyte 
insulin sensitivity [3,29,30]. It has been estimated that WAT 
contributes about 30% of circulating IL-6, thus, directly 
correlated with adiposity and insulin resistance. One of the best 
candidates for a connection between adiposity and insulin 
resistance is adiponectin which is the adipokine that circulates 
at the highest levels. In the previous study, we confirmed that 
high fat diet induced obese mice have lower adiponectin levels 
compared with lean mice fed a standard diet [10]. In the present 
study, the levels of TNF-α and IL-6 were significantly higher 
in the OBC group than in the NC group, and SBE treatment 
in the OB-SBE group significantly reduced TNF-α  and IL-6 
levels. However, there were no significant changes in the MCP-1 
level between NC, OBC and OB-SBE groups. MCP-1 has already 
been shown to be clearly associated to the obese state in human 
and rodents [31]. The role of TNF-α and IL-6 in weight loss 
related to insulin resistance is well established; for instance, 
studies in obese human, diet therapy and drug treatment have 
both been shown to improve insulin sensitivity and correlate with 
a decreased adipose tissue production of TNF-α  and IL-6 
[1-3,26-28]. However, the studies in weight loss subsequent to 
MCP-1 production are still need to be established [29,30]. 
German et al. [32] reported that although it is known that MCP-1 
levels in circulation are correlated with body weight, weight loss 
led no notable decrease in those levels in contrast to TNF- α 
and IL-6. It is of particular note that the degrees of reduction 
in circulating insulin and cytokine levels were of magnitude 
similar to those seen in our study. Further work, for explaining 
these changes, would be required to determine the significance 
of these results. The changes in cytokines levels measured in 
our study paralleled those of body weight and adipose tissue 
weight, and also reflected changes in HOMA-IR. Although we 
didn’t track directly the sequence of adipose tissue deposition, 
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the results which showed changes in serum inflammatory 
cytokine levels, insulin and leptin levels, adipose tissue weight 
and HOMA -IR by high fat diet are in agreement with previous 
reports [26,27,31] which explained the subsequence and relation 
between cytokines and insulin resistance in obesity induction. 
Xu  et al. [26] tracked the expression level of inflammatory 
cytokine genes in WAT of DIO mice to determine whether gene 
regulation occurs prior to the development of systemic insulin 
resistance, which is characterized by hyperinsulinemia. Xu et al. 
[26] reported an increase in inflammatory gene expression as 
early as 3 weeks on high fat diet and a more dramatic up-regulation 
occurred around 16 weeks which was correlated with a marked 
increase in fasting insulin levels. Also, Xu et al. [26] concluded 
that the adipose inflammatory response was increased with an 
increase of adiposity, prior to the increase of fasting insulin level, 
but intensified at the onset of hyperinsulinemia. Wang et al. [31] 
examined the integrated effect of TNF-α  on inflammatory 
cytokine expression in adipocytes and reported that the most 
substantial responses occurred with TNG-α, IL-6 and MCP-1 
itself, expression of each which was strongly upregulated by the 
cytokine. In this study, we confirmed that SBE has the potential 
to reduce adipose tissue deposition and insulin secretion, and 
improve insulin resistance through modulation of secretion of 
the inflammatory cytokines TNF-α and IL-6. However, Ko et 
al. [11] reported that crude extract of Sasa borealis leaves 
contains a potential insulin sensitizer with functions similar to 
that of PPAR-γ agonist and possibly improves glucose utilization 
by enhancing insulin-stimulated glucose uptake and inhibiting 
carbohydrate digestion without affecting insulin secretion in 
vitro. The present study, conducted in vivo and mice were fed 
high fat diet with SBE for 12 weeks, showed significantly 
decreased fasting glucose and insulin levels and resulted in 
favorable changes in HOMA-IR and oral glucose tolerance. 
Therefore, to clarify these conflicting effects, additional work 
will be required to explore which effects of SBE, secretion, 
sensitizer or both contribute to improve glucose homeostasis/ 
insulin resistance in obesity. 
Several studies have suggested various biological and pharma-
cological properties of bamboo leaves extract which may be due 
to the presence of flavones glycosides, phenolic acids, coumarone 
lactones, anthraquinones, and amino acids, and has been utilized 
as therapeutic agents [33]. Park [13] reported that Sasa borealis 
leaves extract have high polyphenol (85.5 mg/g) and flavonoid 
(30.9 mg/g) contents compared to other bamboo species or 
medicinal plants and the major phenolic compounds were 
protocatechuic acid, p-hydroxy benzoic acid, caffeic acid, 
syringic acid, p-cumaric acid, leuteolin-6-glucoside and tricine-7- 
glucoside. Yoon et al. [34] reported that Sasa borealis have 
friedelin and glutiol, a class of triterpenoids and isoorientin, 
tricine 7-O-β-D-glucopyranoside, a class of flavonoid, and 
luteolin 6-C-α-L-arabinopyranoside. Koo et al. [11] suggested 
that triterpenoids present in Sasa borealis leaves extract have 
a potential to inhibit fat deposition. They also proposed that 
flavonoidal glucoside containing Sasa borealis leaves extract 
might have a potential insulin sensitizer. Triterpenoids, which 
are made up of 30 carbons, are considered as a condensation 
compound of six isoprenes [35]. Many kinds of triterpenoid 
extracted from several important Chinese herbal drugs such as 
Panax ginseng and bamboo shavings have been studied 
increasingly and their physiological activities and medicinal 
values have been focused [19]. Jung et al. [36] reported that 
triterpenoids extracted from the root of Rosa rugosa have an 
anti-inflammatory potential. Taken together, these results suggest 
that the effects of SBE in our study might be due to the active 
components, tritepenoids and flavonoids present in BSE. 
However, the exact component and their mechanism of SBE in 
vivo remain to be studied in the future.
In summary, we showed that SBE has beneficial effects on 
weight reduction, retroperitoneal fat deposition and insulin 
secretion and resistance which are accompanied by reduction in 
the secretion of the inflammatory cytokines, TNF-α and IL-6 
except MCP-1in high fat diet fed obese mice. 
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